CD38 polymorphisms in Spanish patients with systemic lupus erythematosus

Area of Science:

• Immunogenetics
• Rheumatology
• Molecular Biology

Background:

• The CD38 gene is a candidate for systemic lupus erythematosus (SLE) susceptibility due to its location in a known risk region and its role in immune cell function.
• CD38 is a molecule involved in leukocyte activation and immune responses, making its genetic variations relevant to autoimmune diseases like SLE.

Purpose of the Study:

• To investigate the association between CD38 gene polymorphisms (intron 1, C/G and exon 3, C/T) and susceptibility to SLE in a Spanish population.
• To explore the relationship between these CD38 polymorphisms and the clinical manifestations of SLE.

Main Methods:

• Genotyping of CD38 gene polymorphisms at positions 182 (intron 1) and 418 (exon 3) using polymerase chain reaction amplification-refractory mutation system (PCR-ARMS).
• Study included 276 Spanish SLE patients and 194 healthy controls.
• Statistical analyses, including logistic regression, were used to assess associations.

Main Results:

• No significant association was found between the studied CD38 polymorphisms and overall SLE susceptibility.
• A significant association was observed between the intron 1 (C/G) polymorphism and discoid rash, a clinical feature of SLE.
• Specifically, the CC genotype was more frequent in patients with discoid rash, while the CG genotype was less frequent compared to controls.

Conclusions:

• The CD38 gene polymorphisms, particularly the intron 1 (C/G) variant, may play a role in the clinical features of SLE, specifically discoid rash.
• Further research is warranted to elucidate the exact contribution of CD38 gene variations to SLE pathogenesis and clinical heterogeneity.